Spin multistability in dissipative polariton channels

We present a model for the theoretical description of the dynamics of a system of spinor cavity polaritons in real space and time, accounting for all relevant types of the interactions and effective magnetic fields. We apply our general formalism for the consideration of the polarization dynamics of the coherently driven, one-dimensional polariton channel. We investigate the effect of the temperature and the longitudinal-transverse splitting on the spin (polarization) multistability and hysteresis arising from the polarization-dependent polariton-polariton interaction. We show that the effect of the phase of the driving laser pump is as important as its strength, and demonstrate that the multistability behavior can survive up to high temperatures in the presence of longitudinal-transverse splitting

Contralateral recurrence of atrial myxoma - case report and review of the literature

Cardiac myxomas are the most frequent cardiac tumors, and they have the capability for recurrence years after resection, in the same or in different cardiac chambers. Hence, follow-up is important. Contralateral recurrences of myxoma are uncommon. We report a 7 year old boy who had a right atrial myxoma resected, and who had recurrent myxoma in the left atrium. The literature regarding such recurrence is reviewed

Left atrial thrombus detection with multiplane transesophageal echocardiography: An echocardiographic study with surgical verification

Background and aim of the study: The detection of left atrial thrombus (LAT) is especially important in patients being evaluated for percutaneous mitral valvuloplasty and elective cardioversion for atrial fibrillation. Transesophageal echocardiography (TEE) is widely used for this indication. This study was undertaken to validate the use of multiplane TEE to detect LAT in the setting of rheumatic mitral valve disease

The use of transesophageal echocardiography guidance of thrombolytic therapy in prosthetic mitral valve thrombosis

Background and aim of the study: The aim of the study was to assess the use of transesophageal echocardiography (TEE) to guide thrombolytic therapy in prosthetic mitral valve thrombosis

Treatment modalities in hypertrophic obstructive cardiomyopathy: Surgical myectomy versus percutaneous septal ablation

Background: The aim of this study was to compare the results of percutaneous septal myocardial ablation (PSMA) and surgical myectomy (SM) for decreasing the left ventricular outflow tract (LVOT) gradient, septal thickness, ventricular dimensions, and mitral regurgitation (MR) in patients with symptomatic hypertrophic obstructive cardiomyopathy

The Effect of High Dose Cilostazol and Rosuvastatin on Periprocedural Myocardial Injury in Patients with Elective Percutaneous Coronary Intervention

Background: The aim of our study was to assess the effect of pretreatment with cilostazol and rosuvastatin combination before elective percutaneous coronary intervention (PCI) on peri-procedural myocardial injury (PPMIJ). Methods: We randomly assigned 172 patients with stable angina pectoris scheduled for elective PCI to pretreatment with Cilostazol 200mg and Rosuvastatin 40 mg (group 1), or to pretreatment with Rosuvastatin 40 mg group (group 2). The primary end-point was the occurrence of PPMIJ defined as any cardiac troponin I (Tn I) level elevated above the upper normal limit (UNL). The occurrence of peri-procedural myocardial infarction (PPMIN) was defined as a post-procedural increase in cTnI level ³ 5 times above the UNL. Results: There was no significant difference in baseline characteristics between group 1 (n = 86) and group 2 (n = 86). The rate of PPMIJ (21% vs. 24%, p = 0.58) and PPMIN (2.3% vs. 7%, p = 0.27) were similar between the two study groups. Subgroup analysis performed on those patients without statin therapy before PCI (53 patients in group 1 and 50 patients in group 2) showed that the incidence of PPMIJ was significantly lower in the group 1 patients without chronic statin treatment [17% (9/53) versus 34% (17/50); p = 0.04], but the rate of PPMIN was similar between the two groups for those patients without chronic statin treatment [1.9% (1/53) versus 10% (5/50); p = 0.07]. Conclusions: We found that adjunct cilostazol and rosuvastatin pre-treatment did not significantly reduce PPMIJ after elective PCI in patients with stable angina pectoris. However, adjunct cilostazol pre-treatment could reduce PPMIJ in patients without chronic statin therapy before elective PCI